Drugs / L. rhamnosus GR-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00479947 | May → Dec 2007 | vulvovaginal candidiasis | Faith Mediplex | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L. rhamnosus GR-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00479947 ↗ |
| Modality | Other / unclassified | “two well documented strains of lactobacilli” NCT00479947 ↗ |
| Route | Oral | “one oral dose of Fluconazole + capsules of L. rhamnosus GR-1 and L reuteri RC-14 containing 5 billion live organisms for 3 months” NCT00479947 ↗ |